G610(P) Retrospective analysis of neonatal deaths secondary to infections in England and Wales, 2013–2015

Autor: L Ahmed, GI Oligbu, L Ferraras, SN Ladhani

Publikováno v: British paediatric allergy immunity and infection group (BPAIIG).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a62f4dd97b96aa2527974b88a7f57ba
https://doi.org/10.1136/archdischild-2020-rcpch.524

Characteristics of children with invasive pneumococcal disease eligible for the 1+1 compared with the 2+1 PCV13 infant immunisation schedule in England: a prospective national observational surveillance study.

Autor: Abdullahi F; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Bertran M; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., D'Aeth JC; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London, UK., Eletu S; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London, UK., Chan YW; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Andrews NJ; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Litt DJ; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London, UK., Ramsay ME; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Ladhani SN; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK; Centre for Neonatal and Paediatric Infections (CNPI), St George's University of London, London, UK. Electronic address: shamez.ladhani@ukhsa.gov.uk.

Publikováno v: The Lancet. Child & adolescent health [Lancet Child Adolesc Health] 2024 Nov; Vol. 8 (11), pp. 788-797. Date of Electronic Publication: 2024 Sep 24.

An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infants.

Autor: Calvert A; Centre for Neonatal and Paediatric Infection and Vaccine Institute, St George's, University of London, London, UK acalvert@sgul.ac.uk.; St George's University Hospitals NHS Foundation Trust, London, UK., Andrews N; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Barlow S; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Borrow R; Vaccine Evaluation Unit, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK., Black C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bromage B; Royal Cornwall Hospitals NHS Trust, Truro, Cornwall, UK., Carr J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Monash University, Clayton, Victoria, Australia., Clarke P; Neonatal Intensive Care Unit, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK.; Norwich Medical School, University of East Anglia, Norwich, UK., Collinson AC; Royal Cornwall Hospitals NHS Trust, Truro, Cornwall, UK., Few K; Neonatal Intensive Care Unit, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK., Hayward N; Centre for Neonatal and Paediatric Infection and Vaccine Institute, St George's, University of London, London, UK.; St George's University Hospitals NHS Foundation Trust, London, UK., Jones CE; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.; NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Le Doare K; Centre for Neonatal and Paediatric Infection and Vaccine Institute, St George's, University of London, London, UK.; Makerere University Johns Hopkins University, Kampala, Uganda.; Pathogen Immunology Group, UK Health Security Agency, Salisbury, UK., Ladhani SN; Centre for Neonatal and Paediatric Infection and Vaccine Institute, St George's, University of London, London, UK.; St George's University Hospitals NHS Foundation Trust, London, UK.; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Louth J; Vaccine Evaluation Unit, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK., Papadopoulou G; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Pople M; Portsmouth Hospitals University NHS Trust, Portsmouth, UK., Scorrer T; Portsmouth Hospitals University NHS Trust, Portsmouth, UK., Snape MD; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Heath PT; Centre for Neonatal and Paediatric Infection and Vaccine Institute, St George's, University of London, London, UK.; St George's University Hospitals NHS Foundation Trust, London, UK.

Publikováno v: Archives of disease in childhood [Arch Dis Child] 2024 Oct 18; Vol. 109 (11), pp. 898-904. Date of Electronic Publication: 2024 Oct 18.

Face masks and protection against COVID-19 and other viral respiratory infections: Assessment of benefits and harms in children.

Autor: Sandlund J; Board-Certified Clinical Microbiologist and Independent Scholar, San Francisco Bay Area, CA, USA. Electronic address: johanna.sandlund@gmail.com., Duriseti R; Clinical Associate Professor, Department of Emergency Medicine, Stanford University Medical Center, Palo Alto, CA, USA., Ladhani SN; Paediatric Infectious Diseases and Vaccinology, St. George's University of London, UK; Consultant Epidemiologist, UK Health Security Agency, London, UK., Stuart K; Speech-Language Pathologist, SmallTalk Pediatric Therapy, San Diego, CA, USA., Noble J; Emergency Medicine and Director of COVID-19 Response, Department of Emergency Medicine, University of California San Francisco, CA, USA., Beth Høeg T; Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Emergency Medicine, University of California San Francisco, CA, USA; Clinical Research, University of Southern Denmark, Copenhagen, Denmark.

Publikováno v: Paediatric respiratory reviews [Paediatr Respir Rev] 2024 Sep 06. Date of Electronic Publication: 2024 Sep 06.

Recent increase in infant pertussis cases in Europe and the critical importance of antenatal immunizations: We must do better…now.

Autor: Khalil A; Fetal Medicine Unit, St George's Hospital, St George's University of London, London, UK; Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK; The Royal College of Obstetricians and Gynaecologists, London, UK. Electronic address: akhalil@sgul.ac.uk., Samara A; Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden; FUTURE, Center for Functional Tissue Reconstruction, University of Oslo, Oslo, Norway., Campbell H; Immunisation and Countermeasures Division, UK Health Security Agency, London, UK., Ladhani SN; Immunisation and Countermeasures Division, UK Health Security Agency, London, UK; Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St George's University of London, London, UK., Amirthalingam G; Immunisation and Countermeasures Division, UK Health Security Agency, London, UK.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Sep; Vol. 146, pp. 107148. Date of Electronic Publication: 2024 Jul 02.